<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T04:11:40Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/113245" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/113245</identifier><datestamp>2025-12-05T11:07:44Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478780</setSpec><setSpec>col_2072_478858</setSpec><setSpec>col_2072_478917</setSpec><setSpec>col_2072_478921</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses</dc:title>
   <dc:creator>Fenutría, Rafael</dc:creator>
   <dc:creator>Martinez, Vanesa Gabriela</dc:creator>
   <dc:creator>Simões, Inês</dc:creator>
   <dc:creator>Postigo, Jorge</dc:creator>
   <dc:creator>Gil, Victor</dc:creator>
   <dc:creator>Martínez-Florensa, Mario</dc:creator>
   <dc:creator>Sintes, Jordi</dc:creator>
   <dc:creator>Naves, Rodrigo</dc:creator>
   <dc:creator>Cashman, Kevin S.</dc:creator>
   <dc:creator>Alberola-Ila, José</dc:creator>
   <dc:creator>Ramos Casals, Manuel</dc:creator>
   <dc:creator>Soldevila, Gloria</dc:creator>
   <dc:creator>Raman, Chander</dc:creator>
   <dc:creator>Merino, Jesús</dc:creator>
   <dc:creator>Merino, Ramón</dc:creator>
   <dc:creator>Engel Rocamora, Pablo</dc:creator>
   <dc:creator>Lozano Soto, Francisco</dc:creator>
   <dc:subject>Cèl·lules B</dc:subject>
   <dc:subject>Cèl·lules T</dc:subject>
   <dc:subject>Limfòcits</dc:subject>
   <dc:subject>Antígens</dc:subject>
   <dc:subject>Melsa</dc:subject>
   <dc:subject>Resposta immunitària</dc:subject>
   <dc:subject>B cells</dc:subject>
   <dc:subject>T cells</dc:subject>
   <dc:subject>Lymphocytes</dc:subject>
   <dc:subject>Antigens</dc:subject>
   <dc:subject>Spleen</dc:subject>
   <dc:subject>Immune response</dc:subject>
   <dc:description>CD5 is a lymphoid-specific transmembrane glycoprotein constitutively expressed on thymocytes and mature T and B1a lymphocytes. Current data support the view that CD5 is a negative regulator of antigen-specific receptor-mediated signaling in these cells, and that this would likely be achieved through interaction with CD5 ligand/s (CD5L) of still undefined nature expressed on immune or accessory cells. To determine the functional consequence of loss of CD5/CD5L interaction in vivo, a new transgenic mouse line was generated (shCD5EμTg), expressing a circulating soluble form of human CD5 (shCD5) as a decoy to impair membrane-bound CD5 function. These shCD5EμTg mice showed an enhanced response to autologous antigens, as deduced from the presentation of more severe forms of experimentally inducible autoimmune disease (collagen-induced arthritis, CIA; and experimental autoimmune encephalitis, EAE), as well as an increased anti-tumoral response in non-orthotopic cancer models (B16 melanoma). This enhancement of the immune response was in agreement with the finding of significantly reduced proportions of spleen and lymph node Treg cells (CD4+CD25+FoxP3+), and of peritoneal IL-10-producing and CD5+ B cells, as well as an increased proportion of spleen NKT cells in shCD5EμTg mice. Similar changes in lymphocyte subpopulations were observed in wild-type mice following repeated administration of exogenous recombinant shCD5 protein. These data reveal the relevant role played by CD5/CD5L interactions on the homeostasis of some functionally relevant lymphocyte subpopulations and the modulation of immune responses to autologous antigens.</dc:description>
   <dc:date>2017-07-03T11:23:15Z</dc:date>
   <dc:date>2017-07-03T11:23:15Z</dc:date>
   <dc:date>2014-01-15</dc:date>
   <dc:date>2017-07-03T11:23:15Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>1932-6203</dc:identifier>
   <dc:identifier>https://hdl.handle.net/2445/113245</dc:identifier>
   <dc:identifier>647387</dc:identifier>
   <dc:identifier>24454761</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0084895</dc:relation>
   <dc:relation>PLoS One, 2014, vol. 9, num. 1, p. e84895</dc:relation>
   <dc:relation>https://doi.org/10.1371/journal.pone.0084895</dc:relation>
   <dc:rights>cc-by (c) Fenutría, Rafael et al., 2014</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>15 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Public Library of Science (PLoS)</dc:publisher>
   <dc:source>Articles publicats en revistes (Biomedicina)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>